Literature DB >> 28675111

Outcomes of Tracheostomy With Concomitant and Delayed Percutaneous Endoscopic Gastrostomy in the Neuroscience Critical Care Unit.

Christa O'Hana S Nobleza1, Vinciya Pandian2,3, Ravirasmi Jasti4, David H Wu5, Marek A Mirski4,5, Romergryko G Geocadin4,5.   

Abstract

BACKGROUND: In patients with severe neurologic conditions, percutaneous endoscopic gastrostomy (PEG) is typically performed either alone or with a tracheostomy. The characteristics and outcomes of patients receiving PEG concomitantly with a tracheostomy (CTPEG) and those receiving delayed PEG (DPEG) after a tracheostomy were compared.
METHODS: Retrospective cohort study in a 24-bed neuroscience critical care unit (NCCU) at a tertiary care hospital. Consecutive patients admitted to the NCCU from April 2007 to July 2013 who underwent percutaneous tracheostomy and gastrostomy by the percutaneous tracheostomy team were included and grouped according to the timing of PEG placement: CTPEG versus DPEG.
RESULTS: Of the 290 patients, 234 (81%) received CTPEG. Demographic and clinical characteristics were similar among the 2 groups except for a lower median (interquartile range [IQR]) body mass index (BMI; 27 [22.67-31.60] versus 30.8 [24.55-40.06], P = .017) and lower rate of acute respiratory distress syndrome (3.85% vs 10.71%, P = .048) in the CTPEG cohort. Furthermore, 59% of CTPEG cohort were neurology patients while 63% of DPEG were neurosurgery patients, P = .004. Primary outcomes showed shorter mean NCCU length of stay (LOS; 25 [12] vs 33 [17] days, P < .001) and median hospital LOS (32 [25-43] vs 37 [31-56] days, P = .002) for the CTPEG cohort. Secondary outcomes showed higher predischarge prealbumin levels (15.6 [7.75] vs 11.58 [5.41], P = .021) and lower median overall hospital cost (US$123 860.20 [US$99 024-US$168 713.40] vs US$159 633.50 [US$121 312-US$240 213.10], P = .0003) in the CTPEG group. Anatomic contraindications were the most common reason for DPEG (30%).
CONCLUSIONS: Among institutions with a tracheostomy team, the practice of tracheostomy with concomitant PEG placement may be considered as feasible as delayed PEG in carefully selected neurocritically ill patients with possible advantages of overall shorter NCCU and hospital LOS, higher predischarge prealbumin, and lower hospital costs. These findings may aid in decisions regarding the timing of PEG placement in the NCCU. Further prospective studies are warranted.

Entities:  

Keywords:  critically ill; gastrostomy; neurocritical care; patient outcomes; tracheostomy

Mesh:

Year:  2017        PMID: 28675111     DOI: 10.1177/0885066617718492

Source DB:  PubMed          Journal:  J Intensive Care Med        ISSN: 0885-0666            Impact factor:   3.510


  3 in total

1.  A Retrospective Observational Study Exploring 30- and 90-Day Outcomes for Patients With COVID-19 After Percutaneous Tracheostomy and Gastrostomy Placement.

Authors:  Stephanie B Kiser; Kate Sciacca; Nelia Jain; Richard Leiter; Emanuele Mazzola; Samantha Gelfand; Jonathan Jehle; Rachelle Bernacki; Daniela Lamas; Zara Cooper; Joshua R Lakin
Journal:  Crit Care Med       Date:  2022-02-21       Impact factor: 7.598

2.  Percutaneous Ultrasound Guided Gastrostomy Tube Placement: A Prospective Cohort Trial.

Authors:  Stephen P Reis; Sidney Z Brejt; Joseph R Weintraub; Noor Ahmad; Jonathan Susman; David G Mobley
Journal:  J Intensive Care Med       Date:  2021-05-06       Impact factor: 3.510

3.  Use of Tracheostomy During the COVID-19 Pandemic: American College of Chest Physicians/American Association for Bronchology and Interventional Pulmonology/Association of Interventional Pulmonology Program Directors Expert Panel Report.

Authors:  Carla R Lamb; Neeraj R Desai; Luis Angel; Udit Chaddha; Ashutosh Sachdeva; Sonali Sethi; Hassan Bencheqroun; Hiren Mehta; Jason Akulian; A Christine Argento; Javier Diaz-Mendoza; Ali Musani; Septimiu Murgu
Journal:  Chest       Date:  2020-06-06       Impact factor: 10.262

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.